Naproxen Sodium
NDC 47781-153, Naproxen Sodium, tablet, film coated, extended release, from Alvogen Inc..
- Product NDC
- 47781-153
- Status
- Listed
- Labeler
- Alvogen Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA020353
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/47781-153 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN SODIUM375 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 47781-153-01 | 47781015301 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (47781-153-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/9225acaa-209f-958b-2c51-9a46995dec33
Use it
Look up 47781-153 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/47781-153 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 47781-153. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.